InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Menu Philippe, Chief Medical Officer. Director active across 1 company, notably SOPHiA GENETICS SA. Cumulatively, 5 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €54k. History available since 2 April 2026. The latest transaction was filed on 6 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations
Philippe Menu is the Chief Medical Officer at SOPHiA GENETICS SA. He is responsible for leading the company's medical initiatives and clinical research. Philippe plays a key role in innovation and the development of new medical solutions, thereby contributing to the growth of SOPHiA GENETICS. His medical expertise is an asset to the company.